Amgen, Takeda join intracellular delivery R&D collaboration by Conor Hale Wednesday, June 5, 2019 Amgen and Takeda signed on to a Canadian consortium to develop a drug delivery technology aiming to help transport proteins directly into cells.
Putting the bio in tech: FierceBiotech tests 'dermoskeleton' by Amirah Al Idrus Wednesday, April 24, 2019 FierceBiotech's Amirah Al Idrus tried out B-Temia's Keeogo, a "dermoskeletic" device that combines sensors, algorithms and motors to help people move.
Pricing a hurdle for next-gen devices, but change is coming by Amirah Al Idrus Friday, April 5, 2019 B-Temia CEO Stéphane Bédard reckons companies such as B-Temia will pave the way to getting reimbursement for this type of robotic device.
Quebec's Amorchem sets up $44M+ life sciences VC by Amirah Al Idrus Wednesday, December 6, 2017 With the launch of its $44.2 million life sciences venture capital fund, the AmorChem Group now has $86 million under management.
